Three-Dimensional Printing of Cell Exclusion Spacers (CES) for Use in Motility Assays
- 4 June 2018
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (8) , 155
Abstract
Cell migration/invasion assays are widely used in commercial drug discovery screening. 3D printing enables the creation of diverse geometric restrictive barrier designs for use in cell motility studies, permitting on-demand assays. Here, the utility of 3D printed cell exclusion spacers (CES) was validated as a cell motility assay.Keywords
This publication has 16 references indexed in Scilit:
- Three-dimensional printing of bioactive hernia meshes: In vitro proof of principleSurgery, 2017
- Anatomic modeling using 3D printing: quality assurance and optimization3D Printing in Medicine, 2017
- Maintaining safety and efficacy for 3D printing in medicine3D Printing in Medicine, 2017
- Additively manufactured medical products – the FDA perspective3D Printing in Medicine, 2016
- A 3D bioprinting system to produce human-scale tissue constructs with structural integrityNature Biotechnology, 2016
- Regulatory Considerations in the Design and Manufacturing of Implantable 3D‐Printed Medical DevicesClinical and Translational Science, 2015
- Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applicationsInternational Journal of Nanomedicine, 2015
- In vitro cell migration and invasion assaysMutation Research - Reviews in Mutation Research, 2013
- A Fast and Accessible Methodology for Micro-Patterning Cells on Standard Culture Substrates Using Parafilm™ InsertsPLOS ONE, 2011
- Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape changeNature, 1981